ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

KESAR ENTERPRISES-Improved Performance

business (LOBs), namely, production of bulk synthetic chemicals, exports and immuno- diagnostics. While viable processes for two bulk drugs based on in-house R and D are in the final stages of development, the company recently launched 'inras'

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Back to Top